Patel PV, Panchal SS, Mehta TA. Improvement of dissolution rate of tacrolimus by solid dispersion technique. J Pharm Investig. 2013;43:45–53. https://doi.org/10.1007/s40005-013-0053-8.

Article  CAS  Google Scholar 

Dasineh S, Akbarian M, Ebrahimi HA, Behbudi G. Tacrolimus-loaded chitosan-coated nanostructured lipid carriers: preparation, optimization and physicochemical characterization. Appl Nanosci. 2021;11:1169–81. https://doi.org/10.1007/s13204-021-01744-4.

Article  CAS  Google Scholar 

Tao C, Huo T, Zhang Q, Song HJPD. Effect of Soluplus on the supersaturation and absorption of tacrolimus formulated as inclusion complex with dimethyl-β-cyclodextrin. Pharm Dev Technol. 2019;24:1076–82. https://doi.org/10.1080/10837450.2019.1630651.

Ahmad Z, Khan MI, Siddique MI, Sarwar HS, Shahnaz G, Hussain SZ, et al. Fabrication and characterization of thiolated chitosan microneedle patch for transdermal delivery of tacrolimus. AAPS PharmSciTech. 2020;21:1–12. https://doi.org/10.1208/s12249-019-1611-9.

Article  CAS  Google Scholar 

Hasan MM, Uddin F, Islam MM, Hasan M, Banik K, Islam MA, et al. Nanotechnology drug delivery system: tools in advance pharmaceutical & human health care. Int J Biopharm. 2016;7:90–9.

Google Scholar 

Tuteja S, Alloway RR, Johnson JA, Gaber AO. The effect of gut metabolism on tacrolimus bioavailability in renaltransplant recipients. Clin transplant. 2001;71:1303–7.

Yousaf R, Khan MI, Akhtar MF, Madni A, Sohail MF, Saleem A, et al. Development and in-vitro evaluation of chitosan and glyceryl monostearate based matrix lipid polymer hybrid nanoparticles (LPHNPs) for oral delivery of itraconazole. Heliyon. 2023;9:1–11. https://doi.org/10.1016/j.heliyon.2023.e14281.

Article  CAS  Google Scholar 

Sultan AA, El-Gizawy SA, Osman MA, El Maghraby GM. Niosomes for oral delivery of nateglinide: in situ–in vivo correlation. J Liposome Res. 2018;28:209–17. https://doi.org/10.1080/08982104.2017.1343835.

Article  CAS  PubMed  Google Scholar 

Khan MI, Madni A, Peltonen L. Development and in-vitro characterization of sorbitan monolaurate and poloxamer 184 based niosomes for oral delivery of diacerein. Eur J Pharm Sci. 2016;95:88–95. https://doi.org/10.1016/j.ejps.2016.09.002.

Article  CAS  PubMed  Google Scholar 

Khan MI, Madni A, Hirvonen J, Peltonen L. Ultrasonic processing technique as a green preparation approach for diacerein-loaded niosomes. AAPS PharmSciTech. 2017;18:1554–63. https://doi.org/10.1208/s12249-016-0622-z.

Article  CAS  PubMed  Google Scholar 

Khan DH, Bashir S, Figueiredo P, Santos HA, Khan MI, Peltonen L. Process optimization of ecological probe sonication technique for production of rifampicin loaded niosomes. J Drug Deliv Sci Technol. 2019;50:27–33. https://doi.org/10.1016/j.jddst.2019.01.012.

Article  CAS  Google Scholar 

Ag Seleci D, Seleci M, Walter J-G, Stahl F, Scheper TJJon. Niosomes as nanoparticular drug carriers: fundamentals and recent applications. J Nanomater. 2016;2016:1–13. https://doi.org/10.1155/2016/7372306.

Bhardwaj P, Tripathi P, Gupta R, Pandey S. Niosomes: a review on niosomal research in the last decade. J Drug Deliv Sci Technol. 2020;56:1–17. https://doi.org/10.1016/j.jddst.2020.101581.

Article  CAS  Google Scholar 

Pardakhty A, Varshosaz J, Rouholamini A. In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. Int J Pharm. 2007;328:130–41. https://doi.org/10.1016/j.ijpharm.2006.08.002.

Article  CAS  PubMed  Google Scholar 

Fazel M, Daeihamed M, Osouli M, Almasi A, Haeri A, Dadashzadeh S. Preparation, in-vitro characterization and pharmacokinetic evaluation of Brij decorated doxorubicin liposomes as a potential nanocarrier for cancer therapy. Iran J Pharm Res. 2018;17:33–43 (PMID: 31011340).

CAS  PubMed  PubMed Central  Google Scholar 

Kreidel RN, Duque MD, Serra CHdR, Velasco MVR, Baby AR, Kaneko TM, et al. Dissolution enhancement and characterization of nimodipine solid dispersions with poloxamer 407 or PEG 6000. J Dispers Sci Technol. 2012;33:1354–9. https://doi.org/10.1080/01932691.2011.605663.

Rehman MU, Rasul A, Waqas MK, Khan MI, Sher M. Development and in vitro characterization of niosomal formulations of immunosuppressant model drug. Pak J Pharm Sci. 2018;31:2623–8.

CAS  PubMed  Google Scholar 

Kashif PM, Madni A, Ashfaq M, Rehman M, Mahmood MA, Khan MI, et al. Development of Eudragit RS 100 microparticles loaded with ropinirole: optimization and in vitro evaluation studies. AAPS PharmSciTech. 2017;18:1810–22. https://doi.org/10.1208/s12249-016-0653-5.

Article  CAS  PubMed  Google Scholar 

Rehman MU, Rasul A, Khan MI, Hanif M, Aamir MN, Waqas MK, et al. Development of niosomal formulations loaded with cyclosporine A and evaluation of its compatibility. Trop J Pharm Res. 2018;17:1457–64. https://doi.org/10.4314/tjpr.v17i8.1.

Article  CAS  Google Scholar 

Zhang Y, Jing Q, Hu H, He Z, Wu T, Guo T, et al. Sodium dodecyl sulfate improved stability and transdermal delivery of salidroside-encapsulated niosomes via effects on zeta potential. Int J Pharm. 2020;580:119183. https://doi.org/10.1016/j.ijpharm.2020.119183.

Yeo LK, Olusanya TO, Chaw CS, Elkordy AA. Brief effect of a small hydrophobic drug (cinnarizine) on the physicochemical characterisation of niosomes produced by thin-film hydration and microfluidic methods. Pharmaceutics. 2018;10:185. https://doi.org/10.3390/pharmaceutics10040185.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Khan MI, Madni A, Ahmad S, Mahmood MA, Rehman M, Ashfaq M. Formulation design and characterization of a non-ionic surfactant based vesicular system for the sustained delivery of a new chondroprotective agent. Braz J Pharm Sci. 2015;51:607–15. https://doi.org/10.1590/S1984-82502015000300012.

Article  CAS  Google Scholar 

Shehata TM, Ibrahim MM, Elsewedy HS. Curcumin niosomes prepared from proniosomal gels: In vitro skin permeability, kinetic and in vivo studies. Polymers. 2021;13:791. https://doi.org/10.3390/polym13050791.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thabet Y, Elsabahy M, Eissa NG. Methods for preparation of niosomes: a focus on thin-film hydration method. Methods. 2022;199:9–15. https://doi.org/10.1016/j.ymeth.2021.05.004.

Article  CAS  PubMed  Google Scholar 

Ribeiro ME, Moura CL, Vieira MG, Gramosa NV, Chaibundit C, de Mattos MC, et al. Solubilisation capacity of Brij surfactants. Int J Pharm. 2012;436:631–5. https://doi.org/10.1016/j.ijpharm.2012.07.032.

Article  CAS  PubMed  Google Scholar 

Peltonen L, Hirvonen J, Yliruusi JJJoc, science i. The effect of temperature on sorbitan surfactant monolayers. J Colloid Interface Sci. 2001;239:134–8. https://doi.org/10.1006/jcis.2001.7520.

Rasul A, Khan MI, Rehman MU, Abbas G, Aslam N, Ahmad S, et al. In vitro characterization and release studies of combined nonionic surfactant-based vesicles for the prolonged delivery of an immunosuppressant model drug. Int J Nanomed. 2020;15:7937–49. https://doi.org/10.2147/IJN.S268846.

Article  CAS  Google Scholar 

Zarrintaj P, Ramsey JD, Samadi A, Atoufi Z, Yazdi MK, Ganjali MR, et al. Poloxamer: a versatile tri-block copolymer for biomedical applications. Acta Biomater. 2020;110:37–67. https://doi.org/10.1016/j.actbio.2020.04.028.

Article  CAS  PubMed  Google Scholar 

Yaghoobian M, Haeri A, Bolourchian N, Shahhosseni S, Dadashzadeh SJIJoN. The impact of surfactant composition and surface charge of niosomes on the oral absorption of repaglinide as a BCS II model drug. Int J Nanomed. 2020;15:8767–81. https://doi.org/10.2147/IJN.S261932.

Tavano L, de Cindio B, Picci N, Ioele G, Muzzalupo R. Drug compartmentalization as strategy to improve the physico-chemical properties of diclofenac sodium loaded niosomes for topical applications. Biomed Microdevices. 2014;16:851–8. https://doi.org/10.1007/s10544-014-9889-6.

Article  CAS  PubMed  Google Scholar 

Giuliano E, Paolino D, Fresta M, Cosco D. Drug-loaded biocompatible nanocarriers embedded in poloxamer 407 hydrogels as therapeutic formulations. Medicines. 2019;6:1–20. https://doi.org/10.3390/medicines6010007.

Article  CAS  Google Scholar 

Junyaprasert VB, Singhsa P, Suksiriworapong J, Chantasart D. Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid. Int J Pharm. 2012;423:303–11. https://doi.org/10.1016/j.ijpharm.2011.11.032.

Article  CAS  PubMed  Google Scholar 

Manosroi A, Wongtrakul P, Manosroi J, Sakai H, Sugawara F, Yuasa M, et al. Characterization of vesicles prepared with various non-ionic surfactants mixed with cholesterol. Colloids Surf B. 2003;30:129–38. https://doi.org/10.1016/S0927-7765(03)00080-8.

Article  CAS  Google Scholar 

Mokhtar M, Sammour OA, Hammad MA, Megrab NA. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int J Pharm. 2008;361:104–11. https://doi.org/10.1016/j.ijpharm.2008.05.031.

Article  CAS  PubMed  Google Scholar 

Verma A, Tiwari A, Saraf S, Panda PK, Jain A, Jain SKJEOoDD. Emerging potential of niosomes in ocular delivery. Expert Opin Drug Deliv. 2021; 18: 55–71. https://doi.org/10.1080/17425247.2020.1822322.

Zaki RM, Ali AA, El Menshawe SF, Bary AA. Formulation and in vitro evaluation of diacerein loaded niosomes. Int J Pharm Pharm Sci. 2014;6:515–21. https://doi.org/10.33263/116.1464014800.

Bayindir ZS, Yuksel N. Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery. J Pharm Sci. 2010;99:2049–60. https://doi.org/10.1002/jps.21944.

Article  CAS  PubMed  Google Scholar 

Waqas MK, Sadia H, Khan MI, Omer MO, Siddique MI, Qamar S, et al. Development and characterization of niosomal gel of fusidic acid: in-vitro and ex-vivo approaches. Des Monomers Polym. 2022;25:165–74. https://doi.org/10.1080/15685551.2022.2086411.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mohamed MI, Kassem MA, Khalil RM, Mohamed M. Enhancement of the anti-inflammatory efficacy of betamethasone valerate via niosomal encapsulation. Biointerface Res Appl Chem. 2021. 11: 14640–60. https://doi.org/10.33263/BRIAC116.1464014660.

Gharbavi M, Amani J, Kheiri-Manjili H, Danafar H, Sharafi AJAips. Niosome: a promising nanocarrier for natural drug delivery through blood-brain barrier. Adv Pharmacol Pharm Sci. 2018; 2018: 6847971. https://doi.org/10.1155/2018/6847971.

Ha JM, Kang SY, Park CW, Bin SA, Rhee YS, Seo JW, et al. Effect of poloxamer on physicochemical properties of tacrolimus solid dispersion improving water solubility and dissolution rate. J Pharm Investig. 2012;42:171–6. https://doi.org/10.1007/s40005-012-0025-4.

Article  CAS  Google Scholar 

Varshosaz J, Pardakhty A, Hajhashemi V-i, Najafabadi AR. Development and physical characterization of sorbitan monoester niosomes for insulin oral delivery. Drug Deliv. 2003;10:251–62. https://doi.org/10.1080/drd_10_4_251.

Khan DH, Bashir S, Correia A, Khan MI, Figueiredo P, Santos HA, et al. Utilization of green formulation technique and efficacy estimation on cell line studies for dual anticancer drug therapy with niosomes. Int J Pharm. 2019;572:118764. https://doi.org/10.1016/j.ijpharm.2019.118764.

Abdelbary G, El-gendy N. Niosome-encapsulated gentamicin for ophthalmic controlled delivery. AAPS PharmSciTech. 2008;9(3):740–7. https://doi.org/10.1208/s12249-008-9105-1.

Article  CAS  PubMed  PubMed Central  Google Scholar